During the last session, Bicara Therapeutics Inc (NASDAQ:BCAX)’s traded shares were 0.52 million. At the end of the trading day, the stock’s price was $12.16, reflecting an intraday gain of 3.40% or $0.4. The 52-week high for the BCAX share is $28.09, that puts it down -131.0 from that peak though still a striking 26.73% gain since the share price plummeted to a 52-week low of $8.91. The company’s market capitalization is $663.00M, and the average intraday trading volume over the past 10 days was 0.5 million shares, and the average trade volume was 470.00K shares over the past three months.

Bicara Therapeutics Inc (NASDAQ:BCAX) trade information

Bicara Therapeutics Inc (BCAX) registered a 3.40% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.40% in intraday trading to $12.16, hitting a weekly high. The stock’s 5-day price performance is 19.80%, and it has moved by -1.94% in 30 days. The short interest in Bicara Therapeutics Inc (NASDAQ:BCAX) is 5.05 million shares and it means that shorts have 8.91 day(s) to cover.

The consensus price target of analysts on Wall Street is $48, which implies an increase of 74.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $48 and $48 respectively. As a result, BCAX is trading at a discount of -294.74% off the target high and -294.74% off the low.

BCAX Dividends

Bicara Therapeutics Inc is due to release its next quarterly earnings on 2025-Mar-26. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Bicara Therapeutics Inc (NASDAQ:BCAX)’s Major holders

Bicara Therapeutics Inc insiders own 0.43% of total outstanding shares while institutional holders control 85.73%, with the float percentage being 86.10%.

Also, the Mutual Funds coming in first place with the largest holdings of Bicara Therapeutics Inc (BCAX) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and T. Rowe Price New Horizons Fund, Inc. . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 636.55 shares. This amounts to just over 1.17 percent of the company’s overall shares, with a $7.74 million market value. The same data shows that the other fund manager holds slightly less at 589.03, or about 1.08% of the stock, which is worth about $7.16 million.